Biotech Values

[DewDiligence]

...it's very much apples and oranges, given the preponderance of data validating the activity of pembro as a drug.

Absolutely right! That's the point that seemed to get lost in today's maze of tweets on this topic.

You may be right about AF's motive, although I would not have considered such a connection if you hadn't brought it up. I was thinking the motive was more pedestrian: increasing the number of eyeballs reading AF’s stuff on Stat. My hunch is that the paid membership on that venue is not what the business people expected.